Eli Lilly and price to book ratio LLY

Market value divided by the book value of the company's net assets, since 2009.

Today, Oct 23, 2026: 35.4×
10-year median: 34.2×
Against its 10-year history: 56th; percentile: 0 is its lowest day, 100 its highest
10-year range: 4.8× to 70.4×
Peer median: 8.0×

Eli Lilly and's price to book ratio is 35.4× as of Oct 23, 2026.

That is above its ten-year median of 34.2×, close to the middle of its last ten years.

Over that time it ranged from 4.8× in Dec 2016 to 70.4× in Jul 2024.

The median for 7 large drugmakers of a similar size is 8.0×.

Price to book ratio over time

median 34.2×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	35.4×	28.6×	42.9×
2025	42.8×	32.4×	61.5×
2024	52.2×	49.7×	70.4×
2023	49.3×	28.1×	52.3×
2022	34.5×	26.6×	40.0×
2021	34.1×	25.4×	41.2×
2020	33.5×	25.9×	59.8×
2019	37.3×	9.3×	46.3×
2018	9.3×	5.6×	10.7×
2017	6.2×	5.3×	6.8×
2016	5.2×	4.8×	6.3×
2015	6.1×	4.4×	6.7×
2014	4.4×	3.4×	4.6×
2013	3.4×	3.3×	4.4×
2012	3.5×	3.0×	4.3×
2011	3.2×	2.7×	3.4×
2010	3.3×	3.2×	4.5×
2009	4.1×	3.9×	4.7×

Against its peers

Companies in Drug Manufacturers - General nearest Eli Lilly and's size, closest first, today.

Company	Price to book ratio
LLYEli Lilly and	35.4×
JNJJohnson & Johnson	7.5×
ABBVAbbVie	n/m
MRKMerck	8.5×
AMGNAmgen	20.3×
GILDGilead Sciences	16.4×
PFEPfizer	2.0×
BMYBristol-Myers Squibb	5.6×
Peer median	8.0×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Eli Lilly and

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.